-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TransCon IL-2 Beta/Gamma in Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TransCon IL-2 Beta/Gamma in Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TransCon IL-2 Beta/Gamma in Renal Cell Carcinoma Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TransCon IL-2 Beta/Gamma in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TransCon IL-2 Beta/Gamma in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TransCon IL-2 Beta/Gamma in Metastatic Colorectal Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TransCon IL-2 Beta/Gamma in Human Papillomavirus (HPV) Associated Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TransCon IL-2 Beta/Gamma in Human Papillomavirus (HPV) Associated Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TransCon IL-2 Beta/Gamma in Human Papillomavirus...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TransCon IL-2 Beta/Gamma in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TransCon IL-2 Beta/Gamma in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TransCon IL-2 Beta/Gamma in...
-
Product Insights
Beta Thalassaemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Beta Thalassaemia - Drugs In Development, 2023’, provides an overview of the Beta Thalassaemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Beta Thalassaemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Interferon Beta – Drugs In Development, 2023
Global Markets Direct’s Interferon Beta provides in depth analysis on Interferon Beta targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Interferon Beta targeted therapeutics development and features...
-
Product Insights
Beta Glucuronidase – Drugs In Development, 2023
Global Markets Direct’s Beta Glucuronidase provides in depth analysis on Beta Glucuronidase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Beta Glucuronidase targeted therapeutics development and features...
-
Product Insights
Beta Klotho – Drugs In Development, 2023
Global Markets Direct’s Beta Klotho provides in depth analysis on Beta Klotho targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Beta Klotho targeted therapeutics development and features...
-
Product Insights
Beta Galactosidase – Drugs In Development, 2023
Global Markets Direct’s Beta Galactosidase provides in depth analysis on Beta Galactosidase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Beta Galactosidase targeted therapeutics development and features...
-
Product Insights
Interleukin 1 Beta – Drugs In Development, 2023
Global Markets Direct’s Interleukin 1 Beta provides in depth analysis on Interleukin 1 Beta targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Interleukin 1 Beta targeted therapeutics...